Evidence map›Paper›PMID 34911656›Full record

ArticleJournal of substance abuse treatment2022

Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma.

Elizabeth J Austin, Judith I Tsui, Michael P Barry, Elyse Tung, Sara N Glick, Michael Ninburg, Emily C Williams

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Syringe Services Participants' Preferences for Wound Care, HIV/Hepatitis C Virus Screening, and Opioid Use Disorder Treatment: A Discrete Choice Experiment.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2026
    Article
  5. Article
  6. Untangling the Web of Hepatitis C Risk in Rural Communities.Journal of general internal medicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Elizabeth J AustinDepartment of Health Systems and Population Health, University of Washington, Seattle, WA, United States of America.
Judith I TsuiDepartment of Medicine, Division of General Internal Medicine, University of Washington, Seattle, WA, United States of America. Electronic address: jtsui@uw.edu.
Michael P BarryDepartment of Epidemiology, University of Washington, Seattle, WA, United States of America; HIV/STD Program, Public Health - Seattle & King County, Seattle, WA, United States of America.
Elyse TungDepartment of Pharmacy, University of Washington, Seattle, WA, United States of America; Kelley-Ross Pharmacy Group, Seattle, WA, United States of America.
Sara N GlickHIV/STD Program, Public Health - Seattle & King County, Seattle, WA, United States of America; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, United States of America.
Michael NinburgHepatitis Education Project, Seattle, WA, United States of America.
Emily C WilliamsDepartment of Health Systems and Population Health, University of Washington, Seattle, WA, United States of America; Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle, WA, United States of America.
University of Washington · USHepatitis B Foundation · USPublic Health – Seattle & King County · USUniversity of Puget Sound · US

Funding

Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject DrugsR34DA047660 · NIDA · UNIVERSITY OF WASHINGTON · PI TSUI, JUDITH · 2019 to 2021
$644k
NIDA NIH HHS R34 DA047660
6 · The paper itself

Abstract

introductionPeople who inject drugs (PWID) have complex health needs and often experience poor health outcomes. For PWID, intersectional experiences of stigma and other social vulnerabilities may influence their experiences navigating medical care. We conducted a targeted subanalysis of qualitative interview data collected to inform development of a community-pharmacist care model for hepatitis C (HCV) among PWID to explore intersectional influences on health care-seeking experiences.

methodsThe study recruited participants from community organizations in Seattle, Washington, and participants were eligible if they reported injection drug use within 3 months and having HCV. Study staff conducted semi-structured interviews and two independent coders transcribed and initially analyzed them using a Rapid Assessment Process, guided by the Consolidated Framework for Implementation Research. Themes emerged regarding intersections of stigma and social vulnerabilities; thus, we conducted a targeted subanalysis guided by Fundamental Cause Theory and Earnshaw et al.'s Stigma Framework.

resultsForty participants (65% male; 47% non-white) reported multiple social vulnerabilities (e.g., regarding unstable housing and food insecurity). Qualitative analysis identified that receiving health care in the context of social vulnerability is challenging and burdensome (Theme 1); health care interactions are fraught with stigma stemming from intersectional vulnerabilities (Theme 2); and the belief that abstaining from drug use is needed to prove worthiness for care (Theme 3). PWID described experiencing multiple social vulnerabilities (e.g., unmet basic needs) that made seeking health care burdensome. Interactions with health care teams further reinforced participants' feelings of shame about their drug use, which influenced how participants expressed their care preferences and felt heard by providers. And as PWID navigated health care, they felt that their status as an active drug user was used to control and sometimes coerce their access to services, discouraging PWID from seeking needed care.

conclusionsStigma and social vulnerabilities play a pervasive and intersecting role in the health care-seeking experiences of PWID and negatively impact their ability to navigate and receive care they need. Evidence-based stigma reduction interventions at multiple levels, coupled with person-centered approaches to care delivery, may help to mitigate negative impacts.

Indexed as

Drug UsersHepatitis CSubstance Abuse, IntravenousFemaleHepacivirusHumansMalePatient Acceptance of Health CarePharmaceutical PreparationsSocial StigmaPharmaceutical PreparationsHepatitis CInjection drug usePatient experienceSocial determinantsStigma

Identifiers

PMID34911656
PMCPMC10586539
OpenAlexW4200477170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.